{"product_id":"9783032393456","title":"Biocompatible Nanomaterials in Immuno-Oncology: Eco-Friendly Drug Delivery Solutions","description":"\u003ch3\u003eBiomaterials, Bioengineering and Sustainability\u003c\/h3\u003e\u003ch1\u003eBiocompatible Nanomaterials in Immuno-Oncology: Eco-Friendly Drug Delivery Solutions\u003c\/h1\u003e\u003ch3\u003eArun Kumar Singh | Meenakshi Dhanawat\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eScience \/ Biotechnology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cem\u003eBiocompatible Nanomaterials in Immuno-Oncology: Eco-Friendly Drug Delivery Solutions \u003c\/em\u003eexplores the convergence of nanotechnology, immunology, and sustainable pharmaceutical sciences to address critical challenges in modern cancer therapy. Although immuno-oncology has revolutionized cancer treatment through immune checkpoint inhibitors, cancer vaccines, adoptive cell therapies, and monoclonal antibodies, their clinical success is often limited by poor tumor targeting, systemic toxicity, immune-related adverse effects, and variable patient responses.\u003c\/p\u003e\n\u003cp\u003eThis volume highlights the potential of biodegradable and biocompatible nanomaterials as advanced drug delivery platforms capable of enhancing the safety, precision, and therapeutic efficacy of immunotherapies. Particular emphasis is placed on naturally derived nanocarriers, including polysaccharides, proteins, lipids, and plant-based polymers, which offer excellent biocompatibility, biodegradability, and reduced environmental impact compared with conventional synthetic materials.\u003c\/p\u003e\n\u003cp\u003eA key focus of the book is the development of eco-friendly nanoparticle fabrication strategies based on green chemistry principles, utilizing plant extracts, microorganisms, and other renewable biological resources. The chapters discuss innovative nanoplatforms for the targeted delivery of immune checkpoint inhibitors, cytokines, nucleic acids, peptides, proteins, and cancer vaccines, while addressing tumor microenvironment modulation and precision therapeutic approaches. Emerging topics such as biomimetic nanoparticles, stimuli-responsive systems, extracellular vesicle-inspired carriers, and artificial intelligence-enabled nanomedicine are also explored.\u003c\/p\u003e\n\u003cp\u003eThe book further examines translational aspects, including manufacturing, quality control, biosafety, regulatory considerations, clinical translation, and commercialization. Written by leading experts across pharmaceutical sciences, oncology, immunology, biomaterials, and nanotechnology, this volume serves as a comprehensive resource for researchers, clinicians, graduate students, industry professionals, and policymakers committed to advancing sustainable, safe, and effective nanotechnology-driven immuno-oncology.\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cstrong\u003eArun Kumar Singh\u003c\/strong\u003e has completed his Master of Pharmacy (M. Pharm) in Pharmaceutics from Galgotias University, Greater Noida, India. Currently, he is serving as an Assistant Professor in the Department of Pharmacy at Rayat Bahra University, where he is actively engaged in both teaching and research.\u003c\/p\u003e\n\u003cp\u003eHis research interests encompass a wide range of emerging and interdisciplinary fields, including nano-formulation, blockchain technology, the Internet of Things (IoT), machine learning, cancer biology, artificial intelligence, big data analytics, and neuroscience. Demonstrating a strong commitment to academic excellence, Mr. Singh has made significant contributions to the scientific community. He has authored one book with IOP Publishing and has contributed five book chapters in the field of big data with the prestigious River Publishers, Denmark. Furthermore, he has published 22 review articles in reputed journals. His research work reflects a cumulative impact factor of 118.56, underlining the quality and influence of his scholarly contributions.\u003c\/p\u003e\n\u003cp\u003eIn addition to journal publications, Mr. Singh has authored and edited 58 books with internationally recognized publishers such as IOP Publishing, Elsevier, CRC Press, and Wiley, demonstrating his broad expertise and dedication to advancing knowledge in pharmaceutical sciences and related areas. Mr. Singh is known for his exceptional research skills, innovative thinking, leadership qualities, effective decision-making, and positive outlook. His diligent work ethic and unwavering commitment to academic and research excellence set him apart as an extraordinary professional in his field. With a passion for driving innovation and fostering interdisciplinary collaboration, Arun Kumar Singh continues to contribute to the growth of pharmaceutical sciences and aims to make a lasting impact in healthcare and technology-driven research.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDr. Meenakshi Dhanawat \u003c\/strong\u003ehas a background in Pharmaceutical Sciences with a specialization in Medicinal Chemistry. She has done Masters from NIPER, Mohali and the project was based on Glycosylamino acids. Her PhD is from IIT-BHU, Varanasi and she worked on CNS drug delivery targeting 5HT1A\/2A receptor. Apart from that she is having a vast experience in extraction of herbal drugs. Area of interest are Synthetic Chemistry, Heterocyclic Chemistry, Nanotechnology, Drug Delivery, Prodrug and Co-Drug Drug Design Complexation, Polymer Chemistry, and their application in drug delivery.\u003c\/p\u003e\n\u003cp\u003eShe is currently working as Associate Professor in Amity Institute of Pharmacy, Amity University Haryana. She has 18 years of teaching and research experience. She has attended several national and international conferences in india and abroad the recipient of the travelship award in DDD section of AAPS-2010, National Biotechnology Conference, California, USA, She has been able to grab the international travel grant from DBT and DST for attending the International Conference at California, USA and Munich, Germany Respectively. She has also grabbed many other fellowships awards, which includes Rajiv Gandhi National Fellowship.\u003c\/p\u003e\n\u003cp\u003eShe has published 85 research\/reviews along with Patent-06, Books 6, Book Chapters 26, Book Editor 25, and Copyright 01.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e29 November 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSpringer Nature Switzerland\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9783032393456\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e540\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Springer Nature Switzerland","offers":[{"title":"Default Title","offer_id":52359435124876,"sku":"9783032393456","price":197.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9783032393456.jpg?v=1786591501","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9783032393456","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}